17-46978977-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_203400.5(RPRML):āc.31T>Gā(p.Leu11Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_203400.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RPRML | NM_203400.5 | c.31T>G | p.Leu11Val | missense_variant | 1/1 | ENST00000322329.5 | NP_981945.1 | |
LRRC37A2 | XM_024450773.2 | c.4810-70079A>C | intron_variant | XP_024306541.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RPRML | ENST00000322329.5 | c.31T>G | p.Leu11Val | missense_variant | 1/1 | 6 | NM_203400.5 | ENSP00000318032.3 | ||
ENSG00000262633 | ENST00000571841.1 | n.676+12351A>C | intron_variant | 5 | ENSP00000461460.1 | |||||
ENSG00000291209 | ENST00000570478.5 | n.291+206A>C | intron_variant | 4 | ||||||
ENSG00000262633 | ENST00000639822.1 | n.568+12351A>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1296316Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 638910
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.31T>G (p.L11V) alteration is located in exon 1 (coding exon 1) of the RPRML gene. This alteration results from a T to G substitution at nucleotide position 31, causing the leucine (L) at amino acid position 11 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.